Prime Therapeutics Names Mike Kolar Senior Vice President, General Counsel

News provided by

Jan 06, 2017, 01:01 ET

ST. PAUL, Minn., Jan. 6, 2017 /PRNewswire/ -- Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving more than 22 million members nationally, has named Mike Kolar as senior vice president, general counsel. He will lead Prime's legal and government affairs areas.

Mike Kolar has been named senior vice president, general counsel, Prime Therapeutics LLC.

Kolar previously held several executive roles, including chief legal and administrative officer, at Virtual Radiologic Corporation (vRad), the country's largest radiology practice and telemedicine enterprise. Kolar also served as chief legal officer of health care reinsurance start-up MOBE, LLC, and as general counsel for Rooster.com, an agribusiness company. His experience also includes service as a partner and in various leadership positions in the corporate finance and transactions group at Oppenheimer Wolff & Donnelly LLP.

"With more than 20 years experience, Mike's deep knowledge of a variety of health care sectors brings fresh perspective and vigor to Prime as we work to transform the pharmacy benefit management industry," said Prime's President and CEO Jim DuCharme. "I look forward to tapping Mike's leadership to help our legal department prepare for the evolving needs of our company and industry."

Kolar earned his Bachelor's degree from the University of Notre Dame and his Juris Doctor from William Mitchell College of Law (now Mitchell Hamline School of Law) in St. Paul, Minn.

About Prime Therapeutics
Prime Therapeutics LLC (Prime) helps people get the medicine they need to feel better and live well. Prime manages pharmacy benefits for health plans, employers, and government programs including Medicare and Medicaid. The company processes claims and delivers medicine to members, offering clinical services for people with complex medical conditions. Prime serves just over 22 million people. It is collectively owned by 14 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans.

For more information, visit www.primetherapeutics.com or follow @Prime_PBM on Twitter.